Results 111 to 120 of about 49,464 (141)
Some of the next articles are maybe not open access.
Clinical Therapeutics, 2005
Fluorouracil (FU) is an antimetabolite with activity against numerous types of neoplasms, including those of the breast, esophagus, larynx, and gastrointestinal and genitourinary tracts. Systemic toxicity, including neutropenia, stomatitis, and diarrhea, often occur due to cytotoxic nonselectivity.
Christine M, Walko, Celeste, Lindley
openaire +2 more sources
Fluorouracil (FU) is an antimetabolite with activity against numerous types of neoplasms, including those of the breast, esophagus, larynx, and gastrointestinal and genitourinary tracts. Systemic toxicity, including neutropenia, stomatitis, and diarrhea, often occur due to cytotoxic nonselectivity.
Christine M, Walko, Celeste, Lindley
openaire +2 more sources
Investigational New Drugs, 2000
Drug development has undergone rapid shifts in methodology and the use of rationally derived agents which either target specific tissues or molecules such as receptors or enzymatic sites. Capecitabine is a rationally derived prodrug of 5-fluorouracil which is based upon the known high concentration of the enzyme thymidine phosphorylase in many human ...
openaire +2 more sources
Drug development has undergone rapid shifts in methodology and the use of rationally derived agents which either target specific tissues or molecules such as receptors or enzymatic sites. Capecitabine is a rationally derived prodrug of 5-fluorouracil which is based upon the known high concentration of the enzyme thymidine phosphorylase in many human ...
openaire +2 more sources
Capecitabine leukoencephalopathy
Practical Neurology, 2019Zeid, Yasiry +3 more
openaire +2 more sources